Form 8-K - Current report:
SEC Accession No. 0001437749-22-024885
Filing Date
2022-10-27
Accepted
2022-10-27 09:06:08
Documents
15
Period of Report
2022-10-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20221026_8k.htm   iXBRL 8-K 28100
2 EXHIBIT 99.1 ex_437823.htm EX-99.1 11227
7 image01.jpg GRAPHIC 7140
  Complete submission text file 0001437749-22-024885.txt   185034

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20221027.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20221027_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20221027_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20221027_pre.xml EX-101.PRE 11689
9 EXTRACTED XBRL INSTANCE DOCUMENT dyai20221026_8k_htm.xml XML 2575
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 221335078
SIC: 2836 Biological Products, (No Diagnostic Substances)